Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche, Bristol On The Defensive After Merck's Lung Cancer Wins At ASCO

Jun 06 2018

• By Emily Hayes

Rear view of businessman with suitcase looking at sunset above city

Related Content

Bristol's Opdivo/Yervoy Bid Will Show Whether Tumor Mutation Burden Is Ready For Prime Time

Feb 06 2018

Roche's IMpower150 Gets AACR Applause But Merck's KEYNOTE-189 Big Winner

Apr 17 2018

Merck's Keytruda Enjoys Clean Sweep In Lung Cancer, At Bristol's Expense

Apr 17 2018

Merck's Stellar Keytruda Squamous Lung Cancer Data Refute Naysayers

May 24 2018

Related Companies

Merck & Co., Inc.

Bristol Myers Squibb Company

Roche Holding AG

Eli Lilly and Company

Bristol Myers Squibb Company

Additional Topics

Market Intelligence ImmunoOncology Clinical Trials Commercial ASCO Cancer BioPharmaceutical

More from Immuno-oncology

More from Anticancer

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.